arrow
B

Bruna Calsina

centro nacional de investigaciones oncologicas (cnio)
H指数:21
被引数:1,584

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
2024-12-012
OAAI
SpadaHC: a database to improve the classification of variants in hereditary cancer genes in the Spanish population
2024-07-041
OAAI
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas
2023-09-293
OA
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition

去泛素酶USP9X缺失使肾癌细胞对mTOR抑制敏感

2023-06-016
PRE
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
2023-05-043
OAAI
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
2023-02-2827
OAAI
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma

端粒维持相关基因的分析揭示NOP10是嗜铬细胞瘤/副神经节瘤的新转移风险标志物

CANCERS
IF4.4
2021-09-2315
OAAI
Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas
2021-03-1230
OAAI
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
2020-12-0136
PREAI
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas
2020-11-0146
OA
Targeting pheochromocytoma/paraganglioma with polyamine inhibitors
2020-09-0116
OAAI
CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis
2020-08-138
OAAI
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma
2020-08-0530
OAAI
Germline mutations in the new E1' cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma
2020-01-2915
OAAI
Hsa-miR-139-5p is a prognostic thyroid cancer marker involved in HNRNPF-mediated alternative splicing
2019-08-2837
OAAI
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma
2019-08-0922
OAAI